Subscribe To
2 top biotech stocks ready for a bull run
With more to their businesses than COVID-19 revenue, these two companies have huge market opportunities ahead....
March 9, 2022, 7:34 am
7 biotech stocks with key catalysts in march
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 ...
March 9, 2022, 6:24 am
Nuvalent to present new preclinical data on ros1-selective inhibitor nvl-520 and alk-selective inhibitor nvl-655 at aacr annual meeting 2022
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clin...
March 8, 2022, 5:38 pm
Omega therapeutics to present preclinical data for otx-2002 at the american association for cancer research annual meeting 2022
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneeri...
March 8, 2022, 5:05 pm
Adaptive biotechnologies lays off about 100 people, 12% of headcount, to ‘streamline our workforce'
Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned....
March 8, 2022, 4:47 pm
Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...
March 8, 2022, 4:45 pm
Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...
March 8, 2022, 4:45 pm
Why crispr therapeutics stock is soaring today
Despite big gains today, the biotech specialist's share price is still down roughly 46% over the past y...
March 8, 2022, 4:18 pm
Learning lessons from 3 stocks flourishing in a desperate biotech bear market
biotech has been the worst performing sector of the stock market across the past 12 months....
March 8, 2022, 2:25 pm
Sigilon therapeutics to present at the barclays global healthcare conference
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop function...
March 8, 2022, 7:00 am
Is a rise imminent for intellia therapeutics stock after 30% fall in a month?
The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31%...
March 8, 2022, 6:30 am
Why bluebird bio stock is sinking today
The biotech's financial position has some investors worried....
March 7, 2022, 2:58 pm
Why bluebird bio stock is sinking today
The biotech's financial position has some investors worried....
March 7, 2022, 2:58 pm
Why bluebird bio stock is sinking today
The biotech's financial position has some investors worried....
March 7, 2022, 2:58 pm
Why allakos stock sank 17.3% in february
The biotech stock has lost roughly 96% of its value over the last year....
March 7, 2022, 10:39 am
Why allakos stock sank 17.3% in february
The biotech stock has lost roughly 96% of its value over the last year....
March 7, 2022, 10:39 am
Why allakos stock sank 17.3% in february
The biotech stock has lost roughly 96% of its value over the last year....
March 7, 2022, 10:39 am
Neubase to present at oppenheimer's 32nd annual healthcare conference
PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...
March 7, 2022, 8:00 am
Neubase to present at oppenheimer's 32nd annual healthcare conference
PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...
March 7, 2022, 8:00 am
Neubase to present at oppenheimer's 32nd annual healthcare conference
PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech...
March 7, 2022, 8:00 am